BiVictriX sees positive final data in BVX001 leukaemia drug

BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF) has received positive final results from the second in vivo efficacy study of its lead clinical cancer...

Related Keywords

United States , , Trademark Office , Bivictrix Therapeutics , Acute Myeloid Leukaemia , Tiffany Thorn , United States Patent ,